EXPLORATORY ANALYSES FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY

被引：0

作者：

Cappelli, F.

Kale, P.

Maurer, M.

Fontana, M.

Grogan, M.

Fernandes, F.

Palacek, T.

Taylor, M.

Hung, R.

Gonzalez-duarte, A.

Puolsen, S.

Donal, E.

Perfetto, F.

Tsujita, K.

Yu, W.

Sarswat, N.

White, M.

Yureneva, E.

Jay, P.

Vest, J.

Gillmore, J.

机构：

[1] AOU Careggi, Florence, Italy

[2] Baylor Univ, Med Ctr, Adv Heart Failure & Transplant Dept, Dallas, TX USA

[3] Columbia Univ, Med Ctr, New York, NY USA

[4] UCL, Royal Free Hosp, Div Med, London, England

[5] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, NY USA

[6] Hcfmusp, Inst Coracao, Sao Paulo, Brazil

[7] First Fac Med, Dept Med 62, Dept Cardiovasc Med, Prague, Czech Republic

[8] Univ Sydney, Dept Clin Immunol & Allergy, Westmead Hosp, Sydney, NSW, Australia

[9] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia

[10] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Dept Med, Nashville, TN USA

[11] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[12] Aarhus Univ Hosp, Aarhus, Denmark

[13] Univ Rennes, INSERM, Ltsi Umr 1099, Ctr Hosp, Rennes, France

[14] Careggi Univ Hosp, Dept Clin & Expt Med, Florence, Italy

[15] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan

[16] Taipei Vet Gen Hosp, Taipei, Taiwan

[17] Univ Chicago, Dept Med, Chicago, IL USA

[18] Alnylam Pharmaceut, Cambridge, England

[19] UCL Med Sch, Royal Free Hosp, Natl Amyloidosis Ctr, London, England

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P352

引用

页数：2

共 50 条

[21] STUDY DESIGN AND RATIONALE OF HELIOS-B: A PHASE 3 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF VUTRISIRAN IN PATIENTS WITH ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY
Shilling, Rebecca
Karsten, Verena
Silliman, Nancy
Chen, Jihong
Li, Wei
Vest, John
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 3579 - 3579
[22] Impact of prior TTR stabilizer use in patients with hereditary Transthyretin-Mediated Amyloidosis in the APOLLO phase-3 study of Patisiran
Coelho, T.
Adams, D.
Gonzalez-Duarte, A.
O'Riordan, W.
Yang, C-C.
Yamashita, T.
Kristen, A.
Tournev, I.
Schmidt, H.
Berk, J.
Lin, K-P.
Gandhi, P.
Sweetser, M.
Chen, J.
Goyal, S.
Gollob, J.
Suhr, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 17 - 18
[23] Impact of patisiran on norfolk QOL-DN in patients with hereditary transthyretin-mediated amyloidosis: results from the cardiac subpopulation in the phase 3 apollo study
Merlini, G.
Solomon, S.
Adams, D.
Coelho, T.
Damy, T.
Mauer, M.
Partisano, A. M.
Chen, J.
Karsten, V.
Vest, J.
Suhr, O. L. E.
Kristen, A.
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 383 - 383
[24] Changes in neuropathy stage in patients with hATTR amyloidosis following patisiran treatment: Analysis from APOLLO
Gonzalez-Duarte, Alejandra
Adams, David
O'Riordan, William
Yang, Chih-Chao
Yamashita, Taro
Kristen, Arnt
Tournev, Ivaylo
Schmidt, Hartmut
Coelho, Teresa
Berk, John
Ghandi, Pritesh
Chen, Jihong
Gollob, Jared
Goyal, Sunita
Suhr, Ole
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 400 - 400
[25] Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Obici, Laura
Berk, John L.
Gonzalez-Duarte, Alejandra
Coelho, Teresa
Gillmore, Julian
Schmidt, Hartmut H. -J.
Schilling, Matthias
Yamashita, Taro
Labeyrie, Celine
Brannagan, Thomas H., III
Ajroud-Driss, Senda
Gorevic, Peter
Kristen, Arnt V.
Franklin, Jaclyn
Chen, Jihong
Sweetser, Marianne T.
Wang, Jing Jing
Adams, David
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (03): : 153 - 162
[26] Patisiran, an RNAi therapeutic for patients with hereditary transthyretin-mediated amyloidosis: Sub-analysis in Japanese patients from the APOLLO study
Yamashita, Taro
Ueda, Mitsuharu
Koike, Haruki
Sekijima, Yoshiki
Yoshinaga, Tsuneaki
Kodaira, Minori
Katsuno, Masahisa
Sobue, Gen
Zhang, Xiaoping
White, Matthew T.
Sweetser, Marianne T.
Wang, Jing Jing
Ando, Yukio
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 251 - 260
[27] Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
Lin, Kon-Ping
Yang, Chih-Chao
Lee, Yi-Chung
Lee, Ming-Jen
Vest, John
Sweetser, Marianne T.
White, Matthew T.
Badri, Prajakta
Hsieh, Sung-Tsang
Chao, Chi-Chao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (09) : 975 - 984
[28] HEALTH STATUS IN PATIENTS WITH ATTR CARDIAC AMYLOIDOSIS RECEIVING TAFAMIDIS: RESPONDER ANALYSES FROM ATTR-ACT
Sperry, Brett Wesley
Hanna, Mazen A.
Nativi-Nicolau, Jose
Maurer, Mathew S.
Stewart, Michelle
Wyrwich, Kathleen
Barsdorf, Alexandra
Kapadia, Heli
Floden, Libby
Spertus, John A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 304 - 304
[29] Impact of Patisiran on Norfolk Quality of Life Questionnaire Diabetic Neuropathy (QOL-DN) in patients with Hereditary transthyretin-mediated Amyloidosis: results from the Phase-3 APOLLO study
Obici, L.
Coelho, T.
Adams, D.
Gonzalez-Duarte, A.
O'riordan, W.
Yang, C. -C.
Yamashita, T.
Kristen, A.
Tournev, I.
Schmidt, H.
Berk, J.
Lin, K. -P.
Gandhi, P.
Sweetser, M.
Chen, J.
Goyal, S.
Gollob, J.
Suhr, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 459 - 459
[30] Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study
Adams, David
Gonzalez-Duarte, Alejandra
O'Riordan, William
Yang, Chih-Chao
Yamashita, Taro
Kristen, Arnt
Tournev, Ivaylo
Schmidt, Hartmut
Coelho, Teresa
Berk, John L.
Lin, Kong-Ping
Dyck, Peter J.
Gandhi, Pritesh
Sweetser, Marianne
Chen, Jihong
Goyal, Sunita
Gollob, Jared
Suhr, Ole
NEUROLOGY, 2018, 90

← 1 2 3 4 5 →